VIO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 714
EU - Europa 106
AS - Asia 89
OC - Oceania 1
Totale 910
Nazione #
US - Stati Uniti d'America 714
IT - Italia 70
CN - Cina 56
SG - Singapore 15
VN - Vietnam 13
FI - Finlandia 12
SE - Svezia 9
DE - Germania 8
GB - Regno Unito 3
HK - Hong Kong 2
IN - India 2
AU - Australia 1
BE - Belgio 1
GR - Grecia 1
IE - Irlanda 1
RO - Romania 1
TH - Thailandia 1
Totale 910
Città #
Fairfield 113
Chandler 94
Woodbridge 63
Ashburn 62
Houston 49
Cambridge 45
Wilmington 43
Seattle 39
Beijing 21
San Diego 20
Ann Arbor 16
Medford 14
Princeton 14
Dong Ket 13
Des Moines 11
Helsinki 11
Singapore 10
Padova 9
Roxbury 8
Milan 5
Falls Church 4
New York 4
Olbia 4
Comiso 3
Lido di Jesolo 3
Los Angeles 3
Shanghai 3
Verona 3
Assemini 2
Bari 2
Bolzano 2
Casalbuttano ed Uniti 2
Guangzhou 2
Hong Kong 2
Nanjing 2
Pisa 2
Rome 2
Vigonza 2
Acquaviva Delle Fonti 1
Atlanta 1
Bangkok 1
Boardman 1
Brussels 1
Bucharest 1
Bussolengo 1
Dallas 1
Dongguan 1
Dublin 1
Edinburgh 1
Florence 1
Geislingen an der Steige 1
Jinan 1
Kilburn 1
Lappeenranta 1
London 1
Magdeburg 1
Martellago 1
Ovada 1
Piove Di Sacco 1
Pune 1
Redmond 1
Senigallia 1
Spinea 1
Sydney 1
Turin 1
Totale 734
Nome #
Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria 117
Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak 98
Burden of premature atrial beats in middle-aged endurance athletes with and without lone atrial fibrillation versus sedentary controls 79
Arrhythmias in Myocarditis 73
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies 65
Arrhythmogenic Cardiomyopathy and Sports Activity 61
Myocarditis in the Athlete: Arrhythmogenic Substrates, Clinical Manifestations, Management, and Eligibility Decisions 59
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 59
Criteria for interpretation of the athlete's ECG: a critical appraisal 58
Axillary vein access for permanent pacemaker and implantable cardioverter defibrillator implantation: fluoroscopy compared to ultrasound 55
Differential diagnosis of arrhythmogenic cardiomyopathy: phenocopies versus disease variants 54
Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Athletes with Premature Ventricular Beats 37
Screening of unknown atrial fibrillation through handheld device in the elderly 36
Interpretation and Diagnostic Workup of Premature Ventricular Beats 32
Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD 24
Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options 19
Reply to the Editor—Mexiletine in myotonic dystrophy: Beware of ventricular arrhythmias! 13
Totale 939
Categoria #
all - tutte 4.771
article - articoli 4.378
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 393
Totale 9.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 3 0 0 4 10 7 5 10 16 19 14 18
2020/2021211 10 32 13 17 10 8 4 13 23 24 36 21
2021/2022243 6 35 19 27 11 18 16 18 14 7 26 46
2022/2023193 26 22 10 22 25 18 0 18 28 4 15 5
2023/2024170 3 23 21 14 22 15 31 2 10 10 7 12
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 939